Sales decline 15.75% to Rs 175.18 crore
Net profit of Caplin Point Laboratories declined 2.98% to Rs 102.59 crore in the quarter ended September 2025 as against Rs 105.74 crore during the previous quarter ended September 2024. Sales declined 15.75% to Rs 175.18 crore in the quarter ended September 2025 as against Rs 207.93 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 175.18 | 207.93 | -16 |
| OPM % | 43.30 | 47.21 | - |
| PBDT | 135.02 | 141.15 | -4 |
| PBT | 129.00 | 134.66 | -4 |
| NP | 102.59 | 105.74 | -3 |
Powered by Capital Market - Live News